Feedback / Questions
TNB-738 - TeneoFour, Inc, Ancora Biotech
https://www.businesswire.com/news/home/20211027005122/en/Newly-Formed-Ancora-Biotech-Will-Continue-Operations-of-Teneobio-Spin-offs-After-Successful-Acquisition-of-Teneobio-by-Amgen
Oct 27, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev